Clinical Trial Update: A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457） [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SHR-1210 in combination with AIN457 in patients with metastatic or microsatellite-stable colorectal cancer, spanning Phase 1 and Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• AIN457
• SHR-1210 (camrelizumab)

Snippet

Sponsor: Yanqiao Zhang | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN